Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 1/2 1

Status

Unknown 3Withdrawn 2Terminated 2Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Radiation Injuries 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Hepatitis 1Chemical and Drug Induced Liver Injury 1Brain Injuries 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Steroids × Clear all
NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown
60 enrolled

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

NCT04553510 2020-09-17

Treatment of Bevacizumab Followed by Steroid in RN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
86 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Brain Injuries, Radiation Injuries

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡